scispace - formally typeset
K

Ke Xu

Researcher at China Medical University (PRC)

Publications -  19
Citations -  923

Ke Xu is an academic researcher from China Medical University (PRC). The author has contributed to research in topics: Cancer & Microwave ablation. The author has an hindex of 10, co-authored 18 publications receiving 589 citations.

Papers
More filters
Journal ArticleDOI

Applications of nanoparticles in biomedical imaging.

TL;DR: Nanoparticle-based contrast agents employed in most common biomedical imaging modalities, including fluorescence imaging, MRI, CT, US, PET and SPECT are reviewed, addressing their structure related features, advantages and limitations.
Journal ArticleDOI

Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy.

TL;DR: In vivo anti-tumor experiments demonstrate the high tumor inhibition rate of photothermal-chemotherapy group with a significant synergistic effect, and the biocompatible and biodegradable drug delivery platform based on ZIFs has shown great promise for future clinic cancer therapy.
Journal ArticleDOI

Layered MoS2 Hollow Spheres for Highly-Efficient Photothermal Therapy of Rabbit Liver Orthotopic Transplantation Tumors

TL;DR: The effective elimination of tumors is successfully realized by PTT under the guidance of digital subtraction angiography, computed tomography, and thermal imaging, which provides a new way for tumor-targeting delivery and cancer theranostic application.
Journal ArticleDOI

Oxygen Production of Modified Core–Shell CuO@ZrO2 Nanocomposites by Microwave Radiation to Alleviate Cancer Hypoxia for Enhanced Chemo-Microwave Thermal Therapy

TL;DR: This combined therapy offers many opportunities, such as the production of oxygen from CuO nanoparticles by MW to alleviate hypoxia, the enhancement of combined treatment of MWTT and chemotherapy, and the potential application of CT imaging to visualize the treatment process, which therefore provides a promising method for the clinical treatment of tumors in the future.